<DOC>
	<DOCNO>NCT01022489</DOCNO>
	<brief_summary>Background : Repetitive transcranial magnetic stimulation ( rTMS ) recent therapeutic demonstrate efficacy treatment auditory hallucination patient schizophrenic disorder . Up , target stimulation leave temporoparietal region ( base international 10-20 EEG system ) rTMS deliver low frequency ( 1 Hz ) . High frequency ( 20 Hz ) might allow shorten duration treatment could convenient patient ( 2 day high frequency instead 15 day low frequency ) . Besides high frequency , accurate target take account inter-subjects anatomical variability might increase efficacy . Based great overlap language auditory hallucination network , investigator hypothesize target stimulation high cluster activation induce language task could easier relevant method determine target . The investigator suggest best area locate posterior part leave superior temporal sulcus ( STS ) . Indeed , area consider `` epicenter `` language , i.e. , involve understanding production language auditory hallucination network . Therefore , investigator conduct open pilot study order test interest rTMS high frequency ( 20 Hz ) associate anatomical functional magnetic resonance imaging ( MRI ) neuronavigation 11 schizophrenic patient hallucination . The investigator show significant reduction auditory hallucination ; Seven 11 patient ( 63.8 % ) consider responder day 12 decrease 30 % score Hoffman 's scale ( Auditory Hallucinations Rating Scale ) ; 2 patient present drastic improvement hallucination 12 day rTMS . The investigator also show target base anatomical functional MRI locate intersection leave STS coronal slice across vertical line sylvius sulcus . The aim multicentric double-blind study ( randomize placebo sham ) demonstrate efficacy rTMS high frequency neuronavigation treatment auditory hallucination patient schizophrenia schizo-affective disorder ( DSMIV-R ) . Methods : 72 subject include write consent . After randomization , subject receive double blind either active treatment placebo ( sham coil ) treatment . rTMS : 4 session 13 minute , 2 session day , 20Hz frequency intensity 80 % rest motor threshold deliver . These parameter allow investigator risk epilepsia , one severe side effect . Another mild side effect headache easily treat antalgic drug . The target establish anatomical MRI eventually associate functional MRI treatment . The efficacy treatment evaluate 4 week ( D0 , D1 , D2 , D7 , D14 , D21 D30 ) . The primary assessment percentage patient present decrease 30 % frequency item Auditory Hallucinations Rating Scale ( AHRS ) D1 D30 2 evaluation space 1 week ( Responder patient ) . The secondary assessment : 1- Relative decrease frequency item AHRS D1 D14 ; 2- Evolution total score AHRS D1 , D2 , D7 , D14 , D21 D30 ; 3- Variation score CGI , SUMD , IS , positive , negative , general total PANSS score D0 D14 D30 ; 4- Scores secondary side effect ( adapt UKU ) D2 D7 ; 5- Distances present target classical target base 10-20 EEG system ( T3P3 ) and/or target establish functional MRI ( cluster activation induce listen comprehension task ) .</brief_summary>
	<brief_title>High Frequency Repetitive Transcranial Magnetic Stimulation ( rTMS ) Schizophrenia : Randomized Controlled Study</brief_title>
	<detailed_description />
	<mesh_term>Hallucinations</mesh_term>
	<mesh_term>Schizophrenia</mesh_term>
	<criteria>Patients schizophrenic disorder age 16 65 year old Patients suffer auditory hallucination ( score AHRS &gt; 10 ) undergo antipsychotic treatment patient clinically stabilise ( antipsychotic treatment modification last 2 month Written sign consent Pregnancy breastfeeding patient brain tumor Patients previous history epilepsy Patients already treat rTMS Counterindication MRI rTMS</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Schizophrenia , auditory hallucination , TMS</keyword>
</DOC>